20α-Dihydrotrengestone
| Clinical data | |
|---|---|
| Other names | 20α-DHTG; 20α-Hydroxytrengestone; 6-Chloro-20(S)-hydroxy-9β,10α-pregna-1,4,6-trien-3-one |
| Drug class | Progestin; Progestogen |
| Pharmacokinetic data | |
| Elimination half-life | 8–14 hours |
| Identifiers | |
| CAS Number | |
| Chemical and physical data | |
| Formula | C21H26ClO2 |
| Molar mass | 345.89 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
20α-Dihydrotrengestone (20α-DHTG), also known as 20α-hydroxytrengestone, as well as 6-chloro-20(S)-hydroxy-9β,10α-pregna-1,4,6-trien-3-one, is a progestin and the major active metabolite of trengestone. It appears that trengestone is a prodrug of 20α-DHTG, as it is largely transformed into this metabolite when given orally in humans. 20α-DHTG has potent progestogenic activity similarly to trengestone.